Thesis (Ph. D.)--West Virginia University, 2004 / Title from document title page. Document formatted into pages; contains vii, 350 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 322-346).

Made available in DSpace on 2018-06-27T18:56:01Z (GMT). No. of bitstreams: 2 Amanda Lima de Oliveira.pdf: 513074 bytes, checksum: 393de3a3c8893cb2dad143281cc76ca4 (MD5) Amanda Lima de Oliveira.pdf.jpg: 3435 bytes, checksum: d98e4a9d95435991a70b3e949f124696 (MD5) Previous issue date: 2012-11-30 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Cyclodextrins (CDs) are cyclic oligosaccharides formed by 6 (αCD), 7 (bCD) or 8 (γCD) glucose units with an internal hydrophobic cavity and outside surface hydrophilic. These three derivatives, the b-cyclodextrin (bCD) seems to be the most advantageous for pharmaceutical use for their availability, cavity size and low cost. The CDs have a future quite promising for their properties as greater absorption of drugs through the biological barriers and time of release, however, some types may not be considered non-toxic. The objective of this study was to investigate the intraperitoneal administration of βCD, M-β-CD and HP-ß-CD for 8 weeks with administered dose of 65.65 mg of CDs/kg rats/day, on parameters of biochemical analyzes, enzymes of energy metabolism, enzymes tiolicas sensitive to increase reactive oxygen species and to make this relationship, also evaluate parameters of oxidative stress in cerebral cortex, liver, kidneys and heart of wistar rats. The results showed that for the group treated with βCD there has been a significant increase in serum urea and creatinine levels, indicating nephrotoxicity, however not related to the other parameters. There was also a great reduction in serum levels of iron for the 3 CDs. The heart showed a reduction in the activity of CKmitocondrial and increase for AK by M-β-CD and reduction of CKmit by HP-ß-CD, but showed a reduction in the levels of diclorofluorceina (DCF) to the 3 CDs and protein carbonyl) by βCD. For the rim there was no significant change in comreducao activity of CKmit by HP-β-CD. In liver tissue, the βCD and M-β-CD reduced the activity of PK, but this is not reflected in blood glucose levels. In the cerebral cortex, the βCD reduced the activity of enzymes CK mitochondrial and PK, also reduced TBARS, but increased carbonyl protein. The indices lipidemic reduced reported by other researchers was not observed in this work, because the group of M-β- CD has a significant increase in serum levels of LDL cholesterol, in addition to aspartate aminostransferase AST, albumin, total protein, alkaline phosphatase, sodium, calcium, magnesium and phosphate. Our results indicate that some CDs alter enzymes crucial for energy metabolism, mainly of brain tissue with a reduction in activity and the PK by βCD. If changes in the activity of these enzymes occur in people who use drugs by intraperitoneal route, it is possible that the energy metabolism and brain functioning may be affected causing damage to the tissue. However more studies are needed to elucidate how there was a reduction of serum iron and as the cyclodextrins affect a structure so well protected by blood-brain barrier as the brain. / As ciclodextrinas (CDs) são oligossacarídeos cíclicos formados por 6 (αCD), 7 (bCD) ou 8 (γCD) unidades de glicose com uma cavidade interna hidrofóbica e superfície externa hidrofílica. Destes três derivados, a b-ciclodextrina (bCD) parece ser a mais vantajosa para utilização farmacêutica pela sua disponibilidade, tamanho da cavidade e baixo custo. O interesse pelas CDs se dá pelas suas propriedades como maior absorção dos fármacos através das barreiras biológicas e tempo de liberação, entretanto, alguns tipos não podem ser considerados atóxicas. O objetivo deste estudo foi investigar a administração intraperitoneal de βCD (Beta Ciclodextrina), M-β-CD (Metil Beta Ciclodextrina) e HP-β-CD (Hidroxypropil Beta Ciclodextrina) durante 8 semanas com dose administrada de 65,65 mg das CDs/kg rato/dia, sobre parâmetros de análises bioquímicas, de enzimas do metabolismo energético, enzimas tiólicas sensíveis ao aumento de espécies reativas e para fazer a relação, também avaliar parâmetros de estresse oxidativo em córtex cerebral, fígado, rins e coração de ratos wistar. Os resultados mostraram que para o grupo tratado com βCD houve um aumento significativo nos níveis séricos de uréia e creatinina, indicando nefrotoxidade, porém não relacionada com os demais parâmetros. Também houve uma grande redução nos níveis séricos de ferro para as 3 CDs. O coração apresentou redução na atividade da Creatinaquinase mitocondrial (CKmit) e aumento para Adenilatoquinase (AK) pela M- β-CD e redução da CKmit pela HP-β-CD, porém apresentou uma redução nos níveis de diclorofluoresceína (DCF) para as 3 CDs e carbonilas proteicas pela βCD. Para o rim houve alteração significativa com redução na atividade da CKmit pela HP-β-CD. No tecido hepático, a βCD e M-β-CD reduziram a atividade da Piruvatoquinase (PK), porém isto não refletiu nos níveis glicêmicos. No córtex cerebral, a βCD reduziu a atividade das enzimas CK mitocondrial e PK, também reduziu TBARS (Espécies reativas ao ácido tiobarbitúrico), mas aumentou carbonilas proteicas. Os índices lipidêmicos reduzidos relatados por outros pesquisadores não foi observado neste trabalho, pois o grupo da M-β-CD apresentou um aumento significativo nos níveis séricos de LDL (lipoproteína de baixa densidade), além de AST (aspartato aminostransferase), albumina, proteínas totais, fosfatase alcalina, sódio, cálcio, magnésio e fosfato. Os resultados indicam que algumas CDs alteram enzimas cruciais do metabolismo energético, principalmente do tecido cerebral com redução na atividade da PK pela βCD. Possíveis alterações na atividade destas enzimas podem afetar o metabolismo energético e o funcionamento cerebral causando dano ao tecido. Entretanto mais estudos são necessários para elucidar de que forma ocorreu a redução sérica de ferro e como as ciclodextrinas afetaram uma estrutura tão bem protegida pela barreira hemato-encefálica como a cerebral.

Dissertation (Ph.D.)--University of South Florida, 2006. / Includes vita. Includes bibliographical references (leaves 166-187). Also available online.

Thesis (Ph.D.) -- University of Texas Southwestern Medical Center at Dallas, 2005. / Embargoed. Vita. Bibliography: 133-159.

Les cassures double-brin (DSB) sont des dommages dangereux de l’ADN et représentent un facteur de risque pour la stabilité du génome. Le maintien de l'intégrité du génome est essentiel pour les cellules souches adultes, qui sont responsables de la régénération des tissus endommagés et de l'homéostasie tissulaire tout au long de la vie. La régénération musculaire chez l'adulte repose sur les cellules souches musculaires (cellules satellites, SCs) qui possèdent une remarquable capacité de réparation des DSB, mais dont le mécanisme sous-jacent reste inconnu. Ce projet de thèse consistait à étudier comment la différenciation musculaire est affectée lorsque la réparation des DSB est altérée, et quels sont le(s) mécanisme(s) et les conséquences de ce défaut de réparation sur la régénération musculaire. Au cours de cette étude, il est apparu de façon originale que les facteurs de réparation des DSB peuvent affecter la myogenèse, indépendamment de leur fonction dans la réparation de l'ADN. La présente étude a porté sur le rôle de la protéine kinase dépendante de l'ADN (DNA-PK), un facteur crucial pour la réparation non-homologue des DSBs (NHEJ), au cours de la différenciation musculaire chez la souris. L’étude a ciblé l'activation des SCs et la régénération musculaire in vitro et in vivo et a également abordé la régulation de cette kinase. Le rôle "canonique" de la DNA-PK, et donc du NHEJ, dans les SCs a également été étudié en présence de lésions de l'ADN radio-induites. Le rôle d’ATM, une kinase qui orchestre les réponses cellulaires aux DSB, a également été abordé dans le contexte de la régénération musculaire. Ces résultats confirment la notion émergente du rôle multifonctionnel des protéines de réparation de l’ADN dans d’autres processus physiologiques que la réparation elle-même, ce qui m’a également permis de réaliser une étude bibliographique. Ce travail i) identifie de nouveaux régulateurs de la myogenèse et ii) contribue à la compréhension de la résistance des cellules souches musculaires au stress génotoxique. Ces résultats pourraient avoir des implications dans l'amélioration des thérapies cellulaires de la dysfonction musculaire en agissant sur les régulateurs nouvellement découverts. / DNA double-strand breaks (DSBs) are dangerous DNA damages and a risk factor for genome stability. The maintenance of genome integrity is crucial for adult stem cells that are responsible for regeneration of damaged tissues and tissue homeostasis throughout life. Muscle regeneration in the adult relies on muscle stem cells (satellite cells, SCs) that have a remarkable DSB repair activity, but the underlying mechanism is not known. The aims of the present PhD project were to investigate how muscle differentiation is affected when DSB repair is impaired, and which are the mechanism(s) and the consequences on muscle regeneration. During this study, a novel possibility has arisen, namely that DSB repair factors affects myogenesis independently of their DNA repair activity, suggesting a novel function, not previously anticipated, of these factors. The present study has addressed the role of DNA-dependent protein kinase (DNA-PK), a crucial factor in non-homologous end-joining (NHEJ) repair of DSBs, in muscle differentiation in the mouse. Studies have targeted SC activation and muscle regeneration in vitro and in vivo and also addressed the regulation of this kinase. In parallel the more “canonical” role of DNA-PK, and thereby of NHEJ, has been investigated in SCs via radiation-induced DNA damage. The role of ATM, a kinase that orchestrates cellular responses to DSBs in muscle regeneration has also been addressed. These results support the emerging notion of multifunctional repair proteins in a variety of physiological processes beyond the repair process itself, on which I have conducted a bibliographical study. This work i) identifies novel regulators of myogenesis, and ii) helps understanding the resistance of muscle stem cells to genotoxic stress. It has potential implications for improving cellular therapies for muscle dysfunction by acting on the newly discovered regulators.

No description available.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

Background: Receptor tyrosine kinase, c-Kit (CD117) plays a pivotal role in the maintenance and expansion of hematopoietic stem/progenitor cells (HSPCs). Additionally, over-expression and/or mutational activation of c-Kit have been implicated in numerous malignant diseases including acute myeloid leukemia. However, the translational regulation of c-Kit expression remains largely unknown. Methods and results: We demonstrated that loss of Pim1 led to specific down-regulation of c-Kit expression in HSPCs of Pim1(-/-)mice and Pim1(-/-)2(-/-)3(-/-) triple knockout (TKO) mice, and resulted in attenuated ERK and STAT3 signaling in response to stimulation with stem cell factor. Transduction of c-Kit restored the defects in colony forming capacity seen in HSPCs from Pim1 (-/-) and TKO mice. Pharmacologic inhibition and genetic modification studies using human megakaryoblastic leukemia cells confirmed the regulation of c-Kit expression by Pim1 kinase: i.e., Pim1-specific shRNA knockdown down-regulated the expression of c-Kit whereas overexpression of Pim1 up-regulated the expression of c-Kit. Mechanistically, inhibition or knockout of Pim1 kinase did not affect the transcription of c-Kit gene. Pim1 kinase enhanced c-Kit S-35 methionine labeling and increased the incorporation of c-Kit mRNAs into the polysomes and monosomes, demonstrating that Pim1 kinase regulates c-Kit expression at the translational level. Conclusions: Our study provides the first evidence that Pim1 regulates c-Kit gene translation and has important implications in hematopoietic stem cell transplantation and cancer treatment.

Thesis (Ph.D.)--University of Alabama at Birmingham, 2008. / Title from first page of PDF file (viewed on June 8, 2009). Includes bibliographical references.

Thesis (M.S.)--University of Alabama at Birmingham, 2007. / Title from first page of PDF file (viewed June 30, 2007). Includes bibliographical references (p. 30-36).